Overweight and hypertriglyceridemia are risk factors for liver cirrhosis in middle-aged Swedish men

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 6, 2011, Pages 738-744

  Schult, Andreas ^a   Eriksson, Henry ^a   Wallerstedt, Sven ^a   Kaczynski, Jerzy ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alcoholism; hypertriglyceridemia; liver cirrhosis; overweight

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ALCOHOL ABUSE; ARTICLE; BODY MASS; CLINICAL ARTICLE; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HYPERTRIGLYCERIDEMIA; LIVER CIRRHOSIS; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ALCOHOLISM; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; HYPERTRIGLYCERIDEMIA; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OVERWEIGHT; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SWEDEN;

EID: 79955977196     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.560679     Document Type: Article

References (40)

1. Westwater JO, Fainer D. Liver impairment in the obese. Gastroenterology 1958;34(4):686-93.
2. Zelman S. The liver in obesity. AMA 1952;90(2):141-56.
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346(16):1221-31.
4. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122(6):1649-57. (Pubitemid 34533559)
5. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55(7): 434-8. (Pubitemid 10057164)
6. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology 2000;118(6):1117-23. (Pubitemid 30346988)
7. Knobler H, Schattner A, Zhornicki T, Malnick SD, Keter D, Sokolovskaya N, et al. Fatty liver - an additional and treatable feature of the insulin resistance syndrome. QJM 1999;92(2): 73-9. (Pubitemid 29097631)
8. Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995;22(6):1714-19.
9. Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. Gastroenterology 2003;124(1):248-50. (Pubitemid 36055357)
10. Kaczynski J, Hansson G, Wallerstedt S. Diabetes: one of few remarkable differences in clinicopathologic features between cirrhotic and noncirrhotic Swedes with hepatocellular carcinoma. Dig Dis Sci 2006;51(4):796-802.
11. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132(2): 112-17. (Pubitemid 30044177)
12. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004;8(3):521-33. (Pubitemid 39141140)
13. Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 2003;38(2):420-7. (Pubitemid 36919863)
14. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30(6):1356-62.
15. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121(1): 91-100. (Pubitemid 32591518)
16. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37(4): 917-23. (Pubitemid 36397405)
17. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997;25(1):108-11. (Pubitemid 27014994)
18. Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Cput JC, et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002;35(3):635-8. (Pubitemid 34183969)
19. Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999;29(4):1215-19. (Pubitemid 29168757)
20. Ioannou GN, Weiss NS, Kowdley KV, Dominitz JA. Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. Gastroenterology 2003;125(4):1053-9. (Pubitemid 37193452)
21. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129(1):113-21. (Pubitemid 41002048)
22. Stroffolini T, Sagnelli E, Almasio P, Ferrigno L, Craxi A, Mele A. Characteristics of liver cirrhosis in Italy: results from a multicenter national study. Dig Liver Dis 2004;36(1): 56-60. (Pubitemid 41122225)
23. McCullough AJ, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93(11):2022-36. (Pubitemid 29076847)
24. Haukeland JW, Lorgen I, Schreiner LT, Frigstad SO, Brandsaeter B, Bjoro K, et al. Incidence rates and causes of cirrhosis in a Norwegian population. Scand J Gastroenterol 2007;42(12):1501-8. (Pubitemid 350125547)
25. Gunnarsdottir SA, Olsson R, Olafsson S, Cariglia N, Westin J, Thjodleifsson B, et al. Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomes. Scand J Gastroenterol 2009;44(8):984-93.
26. TibblinG.High blood pressure in men aged 50 - a population study of men born in 1913. Acta Med Scand 1967;470:1-84.
27. Carlson LA, Wadstrom LB. Determination of glycerides in blood serum. Clin Chim Acta; Int J Clin Chem 1959;4(2): 197-205.
28. Cramér K, Isaksson B. An evaluation of the Theorell method for the determination of total serum cholesterol. Scand J Clin Lab Invest 1959;11(2):213-16.
29. Levin K, Linde S. Determination of glucose in blood, cerebrospinal fluid and urine with a new glucose oxidase reagent. Sven Lakartidn 1962;59:3016-26.
30. Kaczynski J, Hansson G, Wallerstedt S. Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area. Br J Cancer 1996;73 (1):128-32. (Pubitemid 26026274)
31. Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004;164 (19):2169-75.
32. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23(2): 201-29. (Pubitemid 34299024)
33. Tibblin G. A population study of 50-year-old men. An analysis of the non-participation group. Acta Med Scand 1965;178(4):453-9.
34. Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Euro Surveill 2008; 13(21).
35. Blackberg J, Braconier JH, Widell A, Kidd-Ljunggren K. Long-term outcome of acute hepatitis B and C in an outbreak of hepatitis in 1969-72. Eur J Clin Microbiol Infect Dis 2000; 19(1):21-6. (Pubitemid 30093377)
36. Weiland O, Berg JV, Bjorvatn B, Flehmig B, Lundbergh P. Acute viral hepatitis A, B and non-A, non-B in Stockholm in the 1950s and 1970s: a comparison. Infection 1981;9(6): 268-74. (Pubitemid 12184705)
37. Kaczyni J, Hansson G, Hermodsson S, Olsson R, Wallerstedt S. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a lowendemic area. Scand J Gastroenterol 1996;31(8): 809-13. (Pubitemid 26255051)
38. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349(9055):825-32. (Pubitemid 27129209)
39. Ostapowicz G, Watson KJ, Locarnini SA, Desmond PV. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 1998;27(6): 1730-5. (Pubitemid 28264702)
40. Welin L, Adlerberth A, Caidahl K, Eriksson H, Hansson PO, Johansson S, et al. Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden. BMC Public Health 2008;8(1):403.